Reuters logo
BRIEF-Recipharm EBITDA margin falls to 12 pct in Q1
April 27, 2017 / 5:53 AM / 5 months ago

BRIEF-Recipharm EBITDA margin falls to 12 pct in Q1

April 27 (Reuters) - Recipharm AB (Publ)

* Q1 net sales amounted to SEK 1,328 million (973), an increase of 37 pct

* Q1 EBITDA SEK 159 million (136) corresponding to an EBITDA margin of 12 pct (14)

* Says despite an exceptionally weak start of year profit wise, underlying business is developing according to our plans and we maintain our sales growth and ebitda-margin objectives along with our leverage targets

* Says confident that these objectives will be achieved Source text for Eikon: Further company coverage: (Stockholm Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below